This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025
This Week at FDA: FDA to Scrutinize Co-Administered Vaccines, New CRLs, and a GLP-1 ‘Green List’September 5, 2025September 15, 2025
This Week at FDA: CDC Director Fired, FDA Advances New MASH Tool, CMC Pilot ExtendedAugust 29, 2025September 3, 2025
FDA Cites Firms for CGMP Violations, Unapproved Products, and Device Reporting IssuesAugust 19, 2025August 26, 2025
This Week at FDA: Prasad’s Back, FDA Considers COVID Authorization, MAHA Draft Report LeakedAugust 15, 2025August 15, 2025
This Week at FDA: PreCheck Manufacturing Program, New FDA Chief Counsel, and MoreAugust 8, 2025August 15, 2025
